category
Nature BME
date
Mar 17, 2026
slug
status
Published
summary
开发了一种仿生平台(iMRAS),能够在体内局部招募、激活和扩增CAR-iNKT细胞,从而增强其抗肿瘤功能,提高癌症免疫治疗的效果。
tags
合成生物学
type
Post
📄 原文题目
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy
🔗 原文链接
💡 AI 核心解读
开发了一种仿生平台(iMRAS),能够在体内局部招募、激活和扩增CAR-iNKT细胞,从而增强其抗肿瘤功能,提高癌症免疫治疗的效果。
📝 英文原版摘要
<p>Nature Biomedical Engineering, Published online: 17 March 2026; <a href="https://www.nature.com/articles/s41551-026-01629-3">doi:10.1038/s41551-026-01629-3</a></p>The iNKT cell-targeted microparticle recruitment and activation system (iMRAS) is a biomimetic platform that serves to locally recruit, activate and expand CAR-iNKT cells in vivo to enhance CAR-iNKT functionality for improved cancer immunotherapy.
- 作者:NotionNext
- 链接:https://tangly1024.com/article/32648bd6-1f96-8131-a72f-c0de16d9b01f
- 声明:本文采用 CC BY-NC-SA 4.0 许可协议,转载请注明出处。
相关文章
